InsiderClue
Insiders · Profile

Prange Karen

Director at AtriCure · SVP&Pres, Uro & Pelvic Health at Boston Scientific. Filing since 10 Dec 2014. CIK 0001566083

ATRC AtriCure, Inc. Director · 4 trades BSX Boston Scientific SVP&Pres, Uro & Pelvic Health · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ATRC AtriCure, Inc.
5 Aug 2026
Director
Sold at will
3,564
$138.28K
13.5%
ATRC AtriCure, Inc.
20 May 2026
Director
Sold at will
3,000
$85.95K
10.2%
ATRC AtriCure, Inc.
5 Mar 2025
Director
Sold at will
6,100
$232.53K
25.5%
ATRC AtriCure, Inc.
8 Jun 2023
Director
Sold at will
713
$34.15K
4.2%
BSX Boston Scientific
8 Mar 2016
SVP&Pres, Uro & Pelvic Health
Sold, plan not stated
14,747
$254.75K
27.8%
BSX Boston Scientific
8 Feb 2016
SVP&Pres, Uro & Pelvic Health
Sold, plan not stated
6,216
$99.79K
20.8%
BSX Boston Scientific
7 Jul 2015
SVP&Pres, Uro & Women's Health
Sold, plan not stated
17,456
$308.31K
50.0%
BSX Boston Scientific
3 Mar 2015
SVP&Pres, Uro & Women's Health
Sold, plan not stated
2,492
$41.84K
12.5%
BSX Boston Scientific
27 Feb 2015
SVP&Pres, Uro & Women's Health
Sold, plan not stated
1,307
$21.96K
7.0%
BSX Boston Scientific
10 Dec 2014
SVP&Pres, Uro & Women's Health
Sold, plan not stated
19,753
$249.61K
53.1%
10 decisions on file.